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CUTTING-EDGE COMMUNICATION
LIN28 Is Selectively Expressed by Primordial
and Pre-Meiotic Germ Cells in the Human Fetal Ovary
Andrew J. Childs, Hazel L. Kinnell, Jing He, and Richard A. Anderson
Germ cell development requires timely transition from primordial germ cell (PGC) self-renewal to meiotic
differentiation. This is associated with widespread changes in gene expression, including downregulation of
stem cell–associated genes, such as OCT4 and KIT, and upregulation of markers of germ cell differentiation and
meiosis, such as VASA, STRA8, and SYCP3. The stem cell–expressed RNA-binding protein Lin28 has recently
been demonstrated to be essential for PGC specification in mice, and LIN28 is expressed in human germ cell
tumors with phenotypic similarities to human fetal germ cells. We have therefore examined the expression of
LIN28 during normal germ cell development in the human fetal ovary, from the PGC stage, through meiosis to
the initiation of follicle formation. LIN28 transcript levels were highest when the gonad contained only PGCs,
and decreased significantly with increasing gestation, coincident with the onset of germ cell differentiation.
Immunohistochemistry revealed LIN28 protein expression to be germ cell–specific at all stages examined. All
PGCs expressed LIN28, but at later gestations expression was restricted to a subpopulation of germ cells, which
we demonstrate to be primordial and premeiotic germ cells based on immunofluorescent colocalization of LIN28
and OCT4, and absence of overlap with the meiosis marker SYCP3. We also demonstrate the expression of the
LIN28 target precursor pri-microRNA transcripts pri-LET7a/f/d and pri-LET-7g in the human fetal ovary, and
that expression of these is highest at the PGC stage, mirroring that of LIN28. The spatial and temporal restriction
of LIN28 expression and coincident peaks of expression of LIN28 and target pri-microRNAs suggest important
roles for this protein in the maintenance of the germline stem cell state and the regulation of microRNA activity
in the developing human ovary.
Introduction
The RNA-binding protein LIN28 was identified as aregulator of developmental timing in Caenorhabtidis ele-
gans [1], and homologous genes exist in diverse species, in-
cluding mammals [2]. LIN28 is expressed in pluripotent stem
cells [3,4] and widely during mammalian embryogenesis
[5,6], but displays restricted expression in adult tissues [5].
LIN28 inhibits the production of mature microRNAs (miR-
NAs) of the LET-7 (Mirlet7) family from precursor pri-miRNA
transcripts [4,7]. LIN28 can also promote mRNA translation
through direct association with target mRNAs [8–11], in-
cluding that encoding the pluripotency-associated transcrip-
tion factor OCT4 [12].
Lin28 is required for normal development of the primor-
dial germ cell (PGC) population in vivo, and for derivation of
PGC-like cells from embryonic stem (ES) cells in vitro [13]. In
the absence of Lin28, Let-7-mediated translational repression
inhibits the production of Blimp1, a key factor in PGC
specification [14,15]. Lin28 expression is detectable in mouse
PGCs from embryonic day (e) 7.5, with Lin28-negative germ
cells first observed at e12.5, corresponding to the time at
which sex determination occurs and immediately before
entry into meiosis in the female [13]. In the postnatal mouse
testis, Lin28 is repressed by retinoic acid (RA), resulting in
increased Let-7 miRNA expression and possibly spermato-
gonial differentiation [16].
LIN28 is expressed by germ cells in the human fetal testis
[17], and in some human gonadal tumors [13,17–19] char-
acterized by retention of a fetal germ cell–like phenotype
[20]. The expression of LIN28 in the developing human fetal
ovary has not been previously reported. Here, we charac-
terize the expression of LIN28 during human ovarian de-
velopment, from the postmigratory PGC stage, through the
onset of meiotic differentiation, to primordial follicle forma-
tion and meiotic arrest.
Results and Discussion
Expression of the LIN28 gene was investigated at 3 ges-
tational ages representing key stages in human fetal ovarian
germ cell differentiation. At 8–11 weeks of gestational age
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(wga), the fetal ovary contains only undifferentiated, prolif-
erating PGCs. By 14–16 wga widespread germ cell differ-
entiation has initiated, with germ cells forming syncytial
clusters and some germ cells initiating meiosis. At 17–20
wga, germ cell clusters begin to break down, forming pri-
mordial follicles containing oocytes arrested at the diplotene
stage of meiosis [21]. At later gestations (beyond 12–13 wga),
germ cells at various stages of differentiation are seen in the
same ovary, arising from considerable asynchrony in the
progression of human fetal ovarian germ cell development
[22,23]. Mitotic PGC-like cells are restricted to the periphery
of the ovary, with progressively more differentiated germ
cells found in a gradient toward the center [22–24].
LIN28 gene expression decreased significantly between 8–
11 wga and 14–16 wga (Fig. 1A) coincident with the onset of
meiotic germ cell differentiation, and remained low at 17–20
wga. This pattern of expression is strikingly similar to that we
have reported previously for POU5F1 (encoding OCT4) [22],
and is the opposite to that observed for markers of more
mature germ cells such as DAZL and VASA [22,23], and genes
encoding proteins involved in meiosis, such as STRA8,
SYCP3, and SPO11, that are upregulated from 11 to 12 wga
[25–27]. This suggests that LIN28 expression is associated with
PGCs in the human fetal ovary and downregulated at the
onset of germ cell differentiation. The paralogous gene LIN28B
has been implicated in the timing of human puberty and
menopause [28], but its expression was unchanged (Fig. 1B).
To establish whether the pattern of LIN28 gene expression
was conserved at the protein level, we performed immuno-
histochemistry for LIN28 on sections of human fetal ovaries.
At 9 wga, intense LIN28 immunostaining was detected ex-
clusively in PGCs, in both the nucleus and the cytoplasm
(Fig. 2A), and was present in all germ cells at this stage. By 14
wga expression was restricted to a population of germ cells
at the periphery of the fetal ovary, with some im-
munopositive germ cells detected deeper in the ovarian
cortex (Fig. 2B). By 18 wga, almost all immunopositive germ
cells were restricted to a thin margin at the periphery of the
ovary (Fig. 2C, D). Large germ cells with cartwheel chro-
matin indicative of the leptotene stage of meiosis [29] dis-
played no staining (Fig. 2D), supporting the hypothesis that
LIN28 expression is downregulated as germ cells differenti-
ate. Additionally, we noted a possible change in the pre-
dominant subcellular localization of the LIN28 protein with
gestation; at 9 wga all germ cells displayed both nuclear and
cytoplasmic staining, while most LIN28-positive germ cells
at 18 wga appeared to have immunonegative nuclei (com-
pare Fig. 2A and Fig. C, D). Ovarian (Fig. 2D) and meso-
nephric (Fig. 2A) somatic cells were immunonegative at all
stages examined, as was the ovarian surface epithelium,
despite recent reports of the isolation of LIN28-positive germ
cell–like cells from the adult ovarian surface epithelium [30],
and the expression of LIN28 by a subpopulation of epithelial
ovarian cancer cells [31]. Negative controls also displayed no
staining (Fig. 2E).
As human germ cell development is highly asynchronous,
we performed double immunofluorescence to compare the
distribution of LIN28 with stage-specific markers of germ
cell maturation, namely, the PGC marker OCT4 [22], and the
meiosis-associated synaptonemal complex protein SYCP3
[32]. We detected extensive overlap between the expression
of LIN28 and OCT4 at 14 wga (Fig. 3A). All OCT4-positive
germ cells appeared to express LIN28, however, OCT4-
negative/LIN28-positive germ cells could also be detected,
revealing persistence of LIN28 expression beyond the stage
at which germ cells downregulate OCT4. High-magnification
confocal images revealed that in germ cells in which LIN28
localized to the nucleus, expression was restricted to a dis-
tinct subnuclear compartment from which OCT4 appeared to
be excluded (Fig. 3B), a finding consistent with previous
reports of nucleolar localization of LIN28 [8]. No coexpres-
sion of LIN28 and SYCP3 was detected at 15 wga at either
the periphery (Fig. 3C) or deeper within the cortex (Fig. 3D)
of the fetal ovary, confirming that LIN28 is downregulated
before extensive germ cell meiotic differentiation. Negative
controls also displayed no staining (insets, Fig. 3A, C). It
appears therefore that in the human fetal ovary LIN28 marks
OCT4-positive PGC-like germ cells and, additionally, a
population of germ cells at a slightly later yet still premeiotic
stage of differentiation.
As LIN28 inhibits the production of mature LET-7 miR-
NAs from precursor pri-miRNA transcripts, we examined
the expression of the LIN28-target pri-LET-7a/f/d and pri-
LET-7g miRNAs during human fetal ovarian development.
FIG. 1. Expression of LIN28 and LIN28B during human fetal ovarian development. Quantitative reverse transcription-
polymerase chain reaction (qRT-PCR) analysis reveals expression of LIN28 (A) to be highest at 8–11 wga, and significantly
lower at 14–16 wga and 17–20 wga, coincident with the onset of germ cell differentiation [***P < 0.001 vs. 8–11 wga (ANOVA
with Neumann-Keuls post hoc testing), n = 6–8 ovaries per gestational group]. LIN28B expression (B) remained unchanged
across gestation. Values denote mean– SEM. ANOVA, analysis of variance; SEM, standard error of the mean.
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FIG. 2. LIN28 expression is germ cell spe-
cific and becomes restricted to a subpopula-
tion of germ cells with increasing gestation.
At 9 wga (A), all germ cells in the gonad (G)
express LIN28 (brown staining) in both the
nucleus and cytoplasm. Somatic cells in the
gonad (G) and mesonephros (M) display no
staining. By 14 wga (B), LIN28-positive cells
are concentrated at the periphery of the
ovary, although some LIN28-positive germ
cells are distributed toward the center of the
ovary. At 18 wga (C), LIN28-positive germ
cells occupy a thin margin at the edge of the
ovary; no staining is detected in more mature
germ cells toward the center of the ovary. (D)
Magnified image of area identified in (C);
meiotic germ cells (identified by their char-
acteristic chromatin arrangement) are LIN28
negative (arrowheads). Somatic cells (SC) in
streams and interspersed between LIN28-
positive germ cells are also immunonegative.
(E) No staining is detected in negative con-
trols. Scale bars in A, B, C, and E: 50mm; D:
20mm.
FIG. 3. LIN28 is expressed in undifferenti-
ated germ cells, but not in those undergoing
meiosis. Double immunofluorescence reveals
the extensive overlap between the expression
domains of LIN28 (green) and OCT4 (red) (A).
All OCT4-positive cells express LIN28, al-
though some germ cells are LIN28-positive
only (arrows). High-magnification images of
the human fetal ovary at 14 wga (B) reveal
that LIN28 occupies a distinct subnuclear
compartment (arrows) from which OCT4
protein is excluded. No colocalization of
LIN28 (green) with the meiosis marker
SYCP3 (red) is detected at 15 wga at the pe-
riphery (C) or deeper within the cortex (D).
No staining is detected on negative controls
(insets, A and C). Scale bars in A, C, and D:
50mm; B: 10mm, blue staining denotes cell
nuclei.
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We found significant decreases in the expression of pri-LET-
7a/f/d and pri-LET-7g (Fig. 4A, B) between 8–11 wga and 14–
16 wga, mirroring the changes in LIN28 expression. These
data suggest that LET-7 miRNAs may be important during
early human germ cell development. Furthermore, the co-
incident peak expression of both LIN28 and its target pri-
miRNAs suggests that in early human germ cells LIN28
maybe required to inhibit the high levels of pri-LET-7 tran-
scripts from being processed into mature miRNAs. In mouse
ES cells, pri-Let-7g expression is directly regulated by Oct4
[33], and the pattern of pri-LET-7 expression reported here,
which reflects that of OCT4, [22] may indirectly suggest that
this regulatory relationship is preserved in human fetal germ
cells.
Conclusions
In this report we have demonstrated the expression of the
RNA-binding protein LIN28 by immature germ cells during
the development of the human fetal ovary. LIN28 is down-
regulated before germ cells have undergone extensive mei-
otic differentiation, a finding consistent with the loss of Lin28
expression in fetal mouse gonads from e12.5 [13], just before
the initiation of meiosis. In mice [34,35] and possibly humans
[25,27] meiotic entry is thought to be promoted by the action
of RA, which has recently been reported to repress Lin28
expression in the postnatal mouse testis [16]. It will be im-
portant to establish therefore whether downregulation of
LIN28 in the human fetal ovary results, in part, from RA-
mediated repression, thus facilitating germ cell entry into
meiosis.
The expression of the LET-7 family precursor pri-miRNAs,
a target of LIN28, also declines with increasing germ
cell differentiation, consistent with a conserved functional
interaction between the two. Elucidation of the LIN28–LET-7
relationship in human germ cells will enhance our under-
standing of how human PGCs switch from the stem cell state
to meiotic differentiation, and provide insight into manipu-
lating these processes for therapeutic intervention.
Materials and Methods
Collection of human fetal ovaries
Ovaries (8–20 weeks of gestation, calculated from the date
of the last menstrual period) were obtained from morpho-
logically normal human fetuses after elective termination of
pregnancy. Informed consent was obtained, and the study
was approved by the Lothian Research Ethics Committee
(study code: LREC 08/S1101/1). Gestational age was deter-
mined by ultrasonography, and further confirmed (for 14–
20-wga specimens) by measurement of foot length. The sex
of 8–11-wga gonads was determined by polymerase chain
reaction (PCR) for the SRY gene as described previously [36],
using the following primers: SRY-Fwd, 5¢-ACAGTAAAGG
CAACGTCCAG-3¢ and SRY-Rev, 5¢-ATCTGCGGGAAG
CAAACTGC-3¢ [37]. Gonads were dissected into Dulbecco’s
phosphate balanced salt solution (Life Technologies) and
either snap-frozen and stored at - 80C for extraction of to-
tal RNA for quantitative reverse transcription (qRT)-PCR
analysis or fixed in Bouin’s solution and processed into
wax by standard methods for immunohistochemistry. All
FIG. 4. Expression of precursor LET-7 pri-microRNA transcripts during human fetal ovarian development. qRT-PCR
analysis reveals developmentally regulated expression of (A) pri-LET-7a/f/d and (B) pri-LET-7g during human fetal ovary
development. Expression of both transcripts is highest at 8–11 wga, and significantly downregulated at 14–16 and 17–20 wga.
***P < 0.001 versus 8–11 wga, **P < 0.01 versus 8–11 wga (ANOVA, with Neumann-Keuls post hoc testing n= 6–8 ovaries per
gestational group). Values denote mean – SEM.
Table 1. Oligonucleotide Primer Sequences Used in SYBR Green Quantitative
Reverse Transcription-Polymerase Chain Reaction Analysis
Gene Forward primer (5¢–3¢) Reverse primer (5¢–3¢) Ref.
LIN28 CGGGCATCTGTAAGTGGTTC CAGACCCTTGGCTGACTTCT [12]
LIN28B GCCCCTTGGATATTCCAGTC TGACTCAAGGCCTTTGGAAG [35]
pri-LET-7a/f/d GCGCGAGGAAACCAGGAT GCACCACAGGAAGGCTTTTTT [36]
pri-LET-7g CAGTAAGAAATATGGTGTGGACCTCA GATGTATTTGTTGTCATGCAAGGAC [36]
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extragonadal tissue, including mesonephroi, was dissected
away from the gonad before freezing.
RNA extraction and qRT-PCR
Total RNA was extracted from fetal ovaries using the
RNeasy Micro and RNeasy Mini kits (QIAGEN) with
on-column DNaseI digestion as per the manufacturer’s in-
structions. First-strand cDNA was prepared using the
Superscript VILO Mastermix kit (Life Technologies). Gene
expression was assessed by qRT-PCR using SYBR green
technology on an ABI7900HT Fast thermal cycler (Life
Technologies) as described previously [36]. The expression
level of each gene of interest was normalized to that of the
housekeeping gene RPL32 within the same sample. Negative
(cDNA prepared in the absence of reverse transcriptase) and
no-template (in which dH2O was substituted for template
cDNA) controls were included to exclude contamination or
amplification of residual genomic DNA. Primer sequences
used in qRT-PCR can be found in Table 1.
Immunohistochemistry
Immunohistochemistry was performed on fixed sections
of fetal ovary as described previously [36]. Briefly, 5-mm-
thick sections of Bouin’s-fixed, paraffin-embedded tissues
were mounted on electrostatically charged glass slides;
dewaxed; and rehydrated through xylene (2 · 5 min) and
graded alcohols [100% (2 · 30 s), 95% (30 s), and 70% (30 s)].
Antigen retrieval was performed by pressure cooking in
0.01 M sodium citrate buffer (pH 6.0) for 5 min, followed by
incubation in 3% (v/v) hydrogen peroxide in methanol for
30 min to block endogenous peroxidase activity. Slides were
subsequently blocked using the avidin/biotin blocking kit
(Vector Laboratories, Inc.) and incubation in Tris Buffered
Saline (TBS), supplemented with 5% bovine serum albumin
(BSA) and 20% normal serum (NS). Polyclonal rabbit anti-
LIN28 primary antibody (AB46020; Abcam) was diluted
1:500 in 5% BSA/NS/TBS and applied to the sections, and
slides were incubated at 4C overnight in a humidified
chamber. Primary antibodies were detected using a goat
anti-rabbit secondary antibody (DAKO; 30 min, diluted
1:500 in BSA/TBS/NS) and incubation with avidin-biotin-
HRP complex (Vector Laboratories). Bound antibodies were
visualized using 3,3-diaminobenzidine tetrahydrochloride
(DAB; DAKO). Negative controls in which the primary
antibody was omitted were included in each experiment.
Slides were counterstained with hematoxylin, dehydrated
through graded alcohols and xylene, and permanently
mounted using PerTex before being photographed on a
Provis (Carl Zeiss Ltd.) microscope with cold-capture
camera (Olympus). A minimum of 4 sections per ovary
were examined.
Immunofluorescence
Double immunofluorescence was performed as described
previously [38] using either rabbit polyclonal anti-SYCP3
(AB15093; Abcam; diluted 1:50,000) or mouse monoclonal
anti-OCT4 (SC-5279, which recognizes only the pluri-
potency-associated OCT4A isoform [39]; Santa Cruz Bio-
technology; diluted 1:250) on day 1 of the procedure, and
rabbit polyclonal anti-LIN28 (AB46020; Abcam; diluted
1:500) primary antibody on day 2. Anti-SYCP3/anti-OCT4
antibodies were detected using a goat anti-mouse or a goat
anti-rabbit peroxidase secondary antibody (Vector Labora-
tories Ltd.; diluted 1:200), and then incubated with Tyr-
amide Fluorescein Green (TSA Plus Cyanine 5 System;
diluted 1:50) for 10 min at room temperature. Anti-LIN28
primary antibody was detected using a goat anti-rabbit
biotinylated secondary antibody (Vector Laboratories Ltd.;
diluted 1:500), followed by incubation with Streptavidin-
488 (Molecular Probes, Invitrogen Life Technologies; di-
luted 1:200) for 1 h at room temperature. Slides were
counterstained with DAPI, and mounted using PermaFluor
Aqueous Mounting Medium (Beckman Coulter). Fluor-
escent images were captured using an LSM510 Meta con-
focal microscope (Carl Zeiss Ltd.). A minimum of 4 sections
per ovary were examined.
Statistical analyses
Gestational range qRT-PCR data (n = 6–8 ovaries from in-
dividual fetuses per gestational group) were analyzed by
one-way analysis of variance with Neumann-Keuls post hoc
testing in Graphpad Prism Software. P values of < 0.05 were
considered statistically significant.
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Note Added in Proof
While this article was in peer review and production, El-
Khairi et al. [40] also reported increasing expression of LIN28 in
the human fetal ovary between 6 and 9 weeks post conception
(approximately equivalent to 8–11 weeks gestational age) and
co-localization of LIN28 with OCT4 in germ cells at this stage.
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